Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
Fundamental & Clinical Pharmacology|March 10, 2009
Unmet needs in oral antiplatelet therapy with ADP receptor blocking agentsSteen HustedInternational Journal of Cardiology|March 14, 2009
Evidence-based prescribing and adherence to antiplatelet therapy--how much difference do they make to patients with atherothrombosis?Steen HustedPostgraduate Medicine|November 23, 2011
Evaluating the risk-benefit profile of the direct-acting P2Y(12) inhibitor ticagrelor in acute coronary syndromesSteen HustedTherapeutics and Clinical Risk Management|March 4, 2015
Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patientsSteen HustedAdvances in Cardiology|August 22, 2012
Antiplatelet therapy in acute coronary syndromes: ticagrelorSteen HustedJournal of the American College of Cardiology|May 12, 2012
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillationGregory Y H Lip, Torben Bjerregaard Larsen, Flemming Skjøth, et al.Thrombosis Research|January 22, 2014
Improvement of anticoagulant treatment using a dynamic decision support algorithm: a Danish Cohort studyPeter Brønnum Nielsen, Søren Lundbye-Christensen, Lars Hvilsted Rasmussen, et al.Thrombosis and Haemostasis|March 1, 2014
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysisFlemming Skjøth, Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, et al.Journal of the American College of Cardiology|March 16, 2015
Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc scoreGregory Y H Lip, Flemming Skjøth, Lars Hvilsted Rasmussen, et al.Drugs & Aging|March 5, 2016
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary SyndromesBianca Rocca, Steen HustedPageof 15